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ABSTRACT
Vascular endothelial growth factor (VEGF)-A is a well-known major
chemoattractant driver of angiogenesis – the formation of new blood
vessels from pre-existing ones. However, the repellent factors that
fine-tune this angiogenic process remain poorly characterized. We
investigated the expression and functional role of endothelial cell-
derived semaphorin 3A (Sema3A) in retinal angiogenesis, using
genetic mouse models. We found Sema3a mRNA expression in the
ganglion cell layer and the presence of Sema3A protein on larger
blood vessels and at the growing front of blood vessels in neonatal
retinas. The Sema3A receptors neuropilin-1 and plexin-A1 were
expressed by retinal blood vessels. To study the endothelial cell-
specific role of Sema3A, we generated endothelial cell-specific
Sema3A knockout mouse strains by constitutive or inducible vascular
endothelial cadherin-Cre-mediated gene disruption. We found that in
neonatal retinas of these mice, both the number and the length of tip
cell filopodiawere significantly increased and the leading edge growth
pattern was irregular. Retinal explant experiments showed that
recombinant Sema3A significantly decreased VEGF-A-induced
filopodia formation. Endothelial cell-specific knockout of Sema3A
had no impact on blood vessel density or skin vascular leakage in
adult mice. These findings indicate that endothelial cell-derived
Sema3A exerts repelling functions on VEGF-A-induced tip cell
filopodia and that a lack of this signaling cannot be rescued by
paracrine sources of Sema3A.
KEYWORDS: Angiogenesis, Blood vessels, Tip cells, Development,
Semaphorin 3A
INTRODUCTION
Blood vessel (BV) development is mostly driven by angiogenesis,
the formation of new BVs from pre-existing ones. Vascular
endothelial growth factor (VEGF)-A is the main driver of
angiogenesis and signals mainly through VEGFR-2 and the co-
receptor neuropilin 1 (Nrp1) (Carmeliet and Jain, 2011). During
sprouting angiogenesis, VEGF-A gradients are sensed by
specialized endothelial cells, so-called tip cells, which form
filopodia and guide the following proliferating stalk cells
(Gerhardt et al., 2003). The pro-angiogenic factors that influence
tip cells have been widely studied; however, the repellent factors that
fine-tune this angiogenic process remain poorly characterized.
Semaphorin 3A (Sema3a) is a secreted protein that mediates anti-
angiogenic properties via the receptor complex formed by Nrp1 and
type A or D1 plexins (Serini et al., 2003; Schwarz et al., 2004;
Guttmann-Raviv et al., 2007). However, the exact role of Sema3A
during angiogenesis is still unclear, because no vascular phenotype
was seen in Sema3a−/− embryos (Vieira et al., 2007) and Nrp1Sema
mice (Gu et al., 2003). Nrp1Sema mice express a mutated form of
Nrp1, which lacks the Sema-binding domain but maintains its
VEGF-induced functions. Sema3A and Nrp1 are more strongly
expressed in tip cells than in stalk cells (Strasser et al., 2010; Fantin
et al., 2013), suggesting an involvement of Sema3A signaling in
sprouting angiogenesis. By taking genetic approaches, we
investigated whether Sema3A might act in an autocrine manner to
fine-tune the angiogenic process during retinal BV development,
which is a well-established model for angiogenesis studies
(Geudens and Gerhardt, 2011).
Our results indicate that during development, endothelial cell-
derived Sema3A specifically exerts repelling functions on tip cell
filopodia, probably via Nrp1 and plexin-A1, and that a lack of
this signaling cannot be rescued by paracrine sources of
Sema3A.
RESULTS AND DISCUSSION
Sema3amRNA is expressed in the retinal ganglion cell layer
and the secreted protein binds to Nrp1- and plexin-A1-
positive blood vessels
We first studied the retinal expression pattern of Sema3A at the
mRNA and protein level. For mRNA expression, we analyzed X-
gal-stained retinal whole mounts of heterozygous Sema3a+/lacZ
pups, which express lacZ under control of the Sema3a promoter. At
postnatal day (P)7, lacZ expression was detected in a dotted pattern
on the entire retina (Fig. 1A). Frozen sections of eyes counterstained
with hematoxylin and eosin revealed lacZ expression in the retinal
ganglion cell layer (GCL) (Fig. 1B), mainly corresponding to the
localization of retinal ganglion cells stained for βIII-tubulin
(Fig. 1C). In retinal whole mounts of P7 pups, Sema3A protein
staining (green) overlapped with CD31 (red) and was especially
strong on larger BVs (Fig. 1D-F) and on the leading edge of
growing BVs (Fig. 1G-I), whereas it was weaker on capillaries of
already established BVs. Sema3A (green) was also present on single
cells in a retinal layer underneath the superficial blood vascular
plexus (Fig. 1J). To investigate whether Sema3A receptors were
also present, we analyzed whole mounts for Nrp1 and plexin-A1
in situ hybridizations in P7 wild-type (WT) retinas. Nrp1 (cyan) co-
stained with isolectin IB4 (Fig. 1K-N, red) and was expressed by the
filopodia of blood vascular tip cells (Fig. 1N). Plxna1 mRNA was
detected in a vessel-like pattern (Fig. 1O). Thus, Sema3A mRNA
was expressed in the GCL, most probably by BV endothelial cells
and retinal ganglion cells. The presence of Sema3A protein on BVs
suggests that secreted Sema3A binds to Nrp1+ and plexin-A1+ BVs,
probably inducing downstream signaling. These findings are in
agreement with the reported presence of Sema3A protein (JoyalReceived 18 June 2015; Accepted 7 January 2016
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et al., 2011; Cerani et al., 2013) and plexin-A1 in the GCL
(Murakami et al., 2001).
Endothelial cell-derived semaphorin 3A decreases filopodia
length and formation
To study the role of endothelial cell-derived Sema3A during
angiogenesis, we crossed Sema3aflox/flox mice with constitutive
VECad-Cre mice, forming Sema3A-cECKO and tested for
endothelial cell-specific knockout by four different approaches.
First, retinal whole mounts of P7 constitutive VECad-Cre-RFP
reporter mice showed an almost complete overlay of RFP and the
BV marker CD31, whereas no overlap with the neuronal marker
TUJ1 was detectable. This suggests that Cre was only active in
endothelial cells (Fig. S1A-D). Second, PCR analysis of ear
samples of Sema3A-cECKO mice demonstrated excision of the
loxP-flanked DNA by detection of the Cre-cut amplicon (650 bp)
together with the floxed amplicon (1600 bp), whereas Sema3A-WT
animals showed only the 1200 bp WT amplicon (Fig. S1E). Third,
FACS-sortedCD45-CD31+ liver endothelial cells of Sema3A-cECKO
pups demonstrated a significant and almost complete reduction of
Sema3a mRNA levels compared with WT littermates (Fig. S1F).
Fourth, retinal whole mounts of Sema3A-cECKO mice showed
weaker staining for Sema3A at the leading edge of growing BVs
compared with WT controls (Fig. S1G-L). Sema3A-cECKO animals
were not compromised because over 100 mice from three generations
were born in the expected mendelian ratios, and they showed no
increased mortality or decreased fertility rates (data not shown).
Constitutive VECad-Cre-driven recombinatory events might not
be purely endothelial cell specific because VE-Cadherin is
expressed in endothelial cells and leukocytes (Nitschke et al.,
2012) in embryonic stages (Monvoisin et al., 2006). Thus, we
performed experiments with inducible VECad-CreERT2;
Sema3Aflox/flox mice (Sem3A-iECKO) and applied tamoxifen at
P1-P3. Both inducible and constitutive Sema3A-ECKO mice
showed no change in BV density, assessed by percentage of IB4+
area, in P7 retinal whole mounts compared with controls (Fig. S2A-
D,K,L). However, at the leading edge of the growing BVs, Sema3A-
cECKO mice showed a trend towards increased tip cell filopodia
numbers and significantly increased filopodia length (Fig. 2A-C,H,
I). Heterozygous Sema3A-cECKO pups showed slightly increased
filopodia length (+28%) compared with WT controls (Fig. 2B).
Because Sema3A-iECKO pups showed similar results with
increased filopodia counts per 100 µm leading edge and increased
filopodia length (Fig. 2D,E,J,K), these results indicate the
dependence of phenotypes on depletion of endothelial cell-
derived Sema3A. Furthermore, as both the tamoxifen-induced as
well as the tamoxifen-independent, constitutive ECKO of Sema3A
show similar tip cell phenotypes, we believe that the observed
phenotypes are due to the Sema3A deletion and not tamoxifen-
related effects. The variability of IB4+ area, filopodia length and
number in Sema3A-WT animals might depend on litter-specific
effects. The front of growing retinal BVs in Sema3A-cECKO pups
was more uneven than in Sema3A-WT littermates, as indicated by a
significant increase in the percentages of longer (>150 µm)
distances between the established blood vessel plexus and the
locally most extended sprouts (Fig. 2F,G,L) – a measurement that
was similarly performed by others (Kim et al., 2011). These
findings suggest that endothelial cell-derived Sema3A influences
the patterning rather than the rate of retinal blood vessel growth.
Because Sema3A was reported to repel pericytes during
lymphatic vessel development (Bouvree et al., 2012; Jurisic et al.,
2012), we investigated whether pericyte coverage around tip cells
was altered in P7 Sema3A-cECKO pups. NG2-stained pericytes did
not co-stain for Nrp1 and showed no grossly changed coverage in
Sema3A-cECKO retinas compared with Sema3A-WT littermates
(Fig. S2E-J). Our findings suggest that endothelial cell-derived
Fig. 1. Sema3a mRNA is expressed in the retinal ganglion cell
layer and the secreted protein binds to Nrp1- and plexin-A1-
positive blood vessels. (A) X-gal-stained retinal whole mount of a
P7 Sema3a+/lacZ mouse. (B) Frozen section of a P7 eye of a
Sema3a+/lacZ mouse shows X-gal-positive cells in the retinal GCL
(arrows). (C) Blood vascular endothelial cells (CD31, green) and
retinal ganglion cells (βIII-tubulin, red) are detectable in the retinal
GCL. (D-I) CD31 (red) overlaps with Sema3A staining (green) in
retinal whole mounts of P7 WT pups especially on larger BVs and
the growing BVs of the leading edge. (J) Sema3A (green) is present
on single cells in a layer below the BVs. (K-M) Retinal whole mounts
of P7 WT pups stained for IB4 (red) and Nrp1 (cyan). (N) Tip cell
filopodia express Nrp1. (O) In situ hybridization analysis shows
vessel-like expression of plexin-A1 in P7 WT retina. GCL, ganglion
cell layer; INL, inner nuclear layer; ONL, outer nuclear layer.
Scale bars: 100 µm in A,K-M,O, 50 µm in B-J and 20 µm in N.
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Sema3A acts in an autocrine fashion on tip cells and reduces
filopodial numbers and length during angiogenesis. This concept is
supported by studies showing higher Sema3A and Nrp1 expression
in tip cells than stalk cells (Strasser et al., 2010; Fantin et al., 2013).
Regulation of tip cell morphology was also found in the oxygen-
induced retinopathy model, where retinal ganglion cell-derived
Sema3A reduced the number of filopodia per tip cell (Joyal et al.,
2011). Interestingly, these data, together with our findings, indicate
that during development, the autocrine signaling loop is necessary
for proper tip cell morphology and a lack of it cannot be rescued by
paracrine sources of Sema3A.
Recombinant Sema3A reduces VEGF-A-induced filopodia
formation
To test whether Sema3A reduces filopodia formation, we incubated
P5 WT retinal explants with recombinant Sema3A and/or
recombinant VEGF-A, or with medium only (Fig. 3A-D).
Filopodia formation, assessed by filopodia counts per 100 µm
leading edge of growing BVs, was significantly induced by VEGF-
A and inhibited by combined treatment with VEGF-A and Sema3A
(Fig. 3E). Sema3A alone did not significantly influence the number
of filopodia. These results support the concept that Sema3A
decreases VEGF-A-induced tip cell filopodia formation and are in
agreement with the reduction of aortic sprouting by Sema3A under
hypoxic conditions (Joyal et al., 2011).
Endothelial cell-specific knockout of Sema3A does not
modulate retinal blood vessel density or vascular leakage in
the skin
To investigate whether endothelial cell-derived Sema3A regulates
retinal angiogenesis at later stages of development, we analyzed
IB4-stained retinal whole mounts of 3- to 12-week-old inducible
and constitutive Sema3A-ECKO mice. Lack of Sema3A did
not affect vessel density of the superficial, intermediate and deep
plexus in both mouse lines (Fig. 4A-F, Fig. S3), in agreement with
previous studies that found no major effect on BV development in
Sema3−/− and Nrp1Sema knockout mice (Gu et al., 2003; Vieira
et al., 2007).
Because systemic Sema3A has been reported to induce BV
permeability (Le Guelte et al., 2012), we next investigated whether
endothelial cell-derived Sema3A regulates steady state or VEGF-A-
induced BV leakage in the skin of adult mice. Systemic injection of
VEGF-A165 increased tissue leakage rates 5- to 7-fold in Sema3A-
WT, heterozygous and homozygous Sema3A-cECKOmice (Fig. 4G-
I). In heterozygous and homozygous Sema3A-cECKO mice, the
tissue leakage rates were not significantly altered compared with WT
littermates in steady state or after injection of VEGF-A (Fig. 4G-I).
Our findings indicate that the dependency of BVs on Sema3A signals
might be related to their maturation status and, potentially, to their
anatomical location. A lack of VECad-Cre-mediated recombinatory
events in the adult blood vessels can be excluded, because the
Fig. 2. Endothelial cell-derived Sema3A decreases filopodia length and
formation. (A-E) Confocal images of IB4-stained retinal whole mounts
focusing on tip cells of WT, heterozygous and homozygous Sema3A-cECKO
littermates (A-C) and of Sema3A-WT and Sema3A-iECKO pups (D,E).
(F,G) Images of IB4-stained retinal whole mounts focusing on the leading edge
of growing BV of WT and homozygous Sema3A-cECKO littermates.
(H,I) Quantification of filopodia length and number per 100 µm leading edge of
BVs in P7 Sema3A-WT, heterozygous and homozygous Sema3A-cECKO
mice and (J,K) in P7 Sema3A-WT control and Sema3A-iECKO animals.
Filopodia length: Sema3A-WT, 18.2±2.2 µm, n=6 pups; Sema3A-cECKO−/+,
23.22±5.24 µm, n=4 pups; Sema3A-cECKO, 24.0±5.6 µm, n=9 pups; one-way
ANOVA, P=0.0128. Sema3A-WT, 10.4±0.7 µm; Sema3A-iECKO, 19.1±
1.1 µm, n=3 pups per group; t-test,P=0.0008. Filopodia number: Sema3A-WT,
12.7±5.3, n=6 pups; Sema3A-cECKO−/+, 12.78±6.08, n=4 pups. Sema3A-
cECKO, 19.1±6.7, n=9 pups; one-way ANOVA, P=0.059; Sema3A-WT, 9.1±
1.6; Sema3A-iECKO, 18.5±4.2, n=3 pups per group; t-test, P=0.031. Dots
represent mean values per mouse and lines indicate the group means.
(L) Quantification of distances between the established BV plexus and the
most extended local sprouts (indicated by the white arrows in F and G), which
are grouped in 10-75 µm, 75-150 µm and >150 µm lengths and expressed as
percentages. Sema3A-WT, 5.27±6.27% in group >150 µm length, n=6 pups;
Sema3A-cECKO, 16.63±10.56% in group >150 μm length, n=9 pups; 12-20
measurements per image, Fisher’s exact test, P=0.028. *P<0.05, ***P<0.001;
n.s., not significant. Scale bars: 20 µm in A-E and 50 µm in F,G.
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VECad-Cre-driven reporter RFP remains highly expressed on adult
endothelial cells in the ears (Nitschke et al., 2012).
Taken together, our findings reveal that endothelial cell-derived
Sema3A does not affect gross BV development or permeability, but
specifically repels VEGF-A-induced tip cell filopodia and thus fine-
tunes the angiogenic response during development.
MATERIALS AND METHODS
In vivo studies
Mice were housed in the animal facility of ETH Zurich. The C57BL/6
mouse strain and mice backcrossed to C57BL/6 were used. Experiments
were performed according to animal protocol 131/2014 approved by the
local veterinary authorities (Kantonales Veterinäramt Zürich). Sema3A-
loxed (Sema3aflox/flox) and Sema3A lacZ knock-in (Sema3a+/lacZ) mice
(Taniguchi et al., 1997) were obtained from RIKEN, Japan. Vascular-
endothelial cadherin (VECad)-CreERT2mice (Monvoisin et al., 2006) were
provided by Dr Luisa Iruela-Arispe (UCLA, CA, USA) and VECad-Cre red
fluorescent protein (RFP) mice (Nitschke et al., 2012) by Dr Cornelia Halin
(ETH Zurich, Switzerland). To generate constitutive endothelial cell-
specific Sema3A KO mice (Sema3A-cECKO), Sema3aflox/flox mice were
crossed with constitutive VECad-Cre mice. To induce endothelial cell-
specific knockout of Sema3A, tamoxifen (0.05 mg, Sigma) diluted in
ethanol/sunflower seed oil (1:9) was injected at P1-P3 intragastrically into
Sema3aflox/flox;VECad-CreERT2 mice (Sema3A-iECKO). Age-matched
Sema3aflox/flox;VECad-CreERT2 mice received vehicle injections. For
further information on genotyping, please refer to supplementary
Materials and Methods.
Fig. 3. Recombinant Sema3A reduces VEGF-A-induced filopodia formation. (A-D) Confocal images of whole mounts of WT retinal explants focusing on the
leading edge of BVs. P5 retinas were cultured in control medium (A), medium containing either 5 µg/ml recombinant Sema3A (B), 1 µg/ml VEGF-A (C), or both
Sema3A and VEGF-A (D). Scale bar: 20 µm. (E) Quantification of filopodia per 100 µm leading edge of growing BVs. Medium, 11.01±1.46; VEGF-A, 19.98±1.32;
combined, 12.47±2.07; n=3 retinas per group, one-way ANOVA, P=0.0007. ***P<0.001; n.s., not significant.
Fig. 4. Endothelial cell-specific knockout of Sema3A
does not modulate retinal blood vessel density or
vascular leakage in the skin. (A-F) Quantification of IB4+
area per region of interest (%) in superficial, intermediate and
deep blood vascular plexus of retinas of Sema3A-WTs,
Sema3A-cECKO (12-week-old) and Sema3A-iECKO
(3-week-old) mice. No significant changes detectable. Dots
represent average values per mouse. Lines represent
average of all mice. (G) Near-infrared images of WT and
Sema3A-cECKO mouse ears during the BV leakage
experiment in steady state and (H) with 1 μg VEGF-A
injection. (I) Quantification of tissue leakage rates in 7-week-
old WT, heterozygous and homozygous Sema3A-cECKO
mice in steady state (+) or with 1 μg VEGF-A injection ($).
Sema3A-WT: steady state, 0.00062±0.00032, n=5 mice;
VEGF-A challenged, 0.00482±0.00253, n=6 mice; t-test,
P=0.0053. Sema3A-cECKO−/+: steady state, 0.0006±
0.00037, n=6 mice; VEGF-A challenged, 0.00395±0.00135,
n=8 mice; t-test, P=0.00000759. Sema3A-cECKO: steady
state, 0.00065±0.00048, n=4 mice; VEGF-A challenged,
0.00336±0.00203, n=5 mice; t-test, P=0.037. Group
comparisons: one-way ANOVA, *P<0.05, **P<0.01,
***P<0.001; n.s., not significant.
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X-gal staining
Whole mounts were produced as described (Karaman et al., 2015) with the
following modifications. Retinas of Sema3a+/lacZ P7 pups were dissected
after fixation and stained overnight. For frozen sections, whole eyes of
Sema3a+/lacZ pups were frozen in optimal cutting temperature (OCT)
compound (Sakura Finetek). 7 µm cryosections were fixed with 0.2%
glutaraldehyde, 5 mM EGTA, 2 mM MgCl2 in PBS. After washing with
2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40 in PBS, slides
were covered with staining solution containing 1 mg/ml X-gal in 5 mM
potassium ferrocyanide {K4[Fe(CN)6}, 5 mM potassium ferricyanide
{K3[Fe(CN)6} and incubated overnight. Then, slides were counterstained
with hematoxylin and eosin.
Immunostaining
For whole mounts, eyes were fixed in 4% paraformaldehyde for 2 h at 4°C
and dissected. Retinas were incubated in PBS containing 5% donkey serum,
1% BSA and 0.1% Triton X-100 (immunomix) and the following antibodies
were added in immunomix overnight: goat anti-Sema3A (Santa Cruz, C-17;
1:20), goat anti-Nrp1 (R&D Systems, AF566; 1:100), rat anti-CD31 (BD
Biosciences Pharmingen, 550274; 1:200). For IB4 staining, samples were
pre-incubated in PBSlec (PBS containing 1 M MnCl2, 1 M MgCl2, 1 M
CaCl2 and 1% Triton-X100) and then incubated overnight in IB4 (Vector
Laboratories, B-1205; 1:25) diluted in PBSlec. After washing, tissues were
incubated with AlexaFluor 488, 594 or 647-conjugated secondary antibodies
(Invitrogen, all 1:200) and mounted in Vectashield (Vector Laboratories) for
confocal imaging. Z-stack images were acquired with an LSM 710 FCS
confocal microscope using Zeiss ZEN 2009 software andwere processed and
quantified with ImageJ software (NIH). For frozen sections, whole eyes of P7
WT pups were frozen in OCT. 7 µm cryosections were fixed with acetone
and methanol and incubated with immunomix before antibody incubation.
Next, respective secondary antibodies were added. Images were acquired
with an Axioskop2 Mot Plus microscope, equipped with an AxioCamMRc
camera using AxioVision Version 4.4 software (Carl Zeiss). Images were
processed and analyzed in a blinded fashion with ImageJ software.
Whole-mount in situ hybridization
In situ hybridization was performed as described (Powner et al., 2012) with
the following modifications: Eyes ofWT pups were pre-fixed in 4% PFA for
10 min and digested for 8 min in 18 µg/ml proteinase K (Roche). Retinas
were hybridized overnight at 65°C with 300 ng of digoxigenin (DIG)-
labeled RNA probe of plexin-A1 per sample. Retinas were stained overnight
at room temperature with NBT/BCIP coloring reagents (Roche). Images
were acquired as described above.
Retinal explant assay
The procedure was performed as described (Sawamiphak et al., 2010) with
the following modifications. Retinas of WT mice were incubated in DMEM
with or without 5 µg/ml recombinant Sema3A-Fc (R&D Systems) for 1 h at
37°C. Then, 1 µg/ml human VEGF165 (R&D Systems) was added alone or
in combination with Sema3A-Fc. After 4 h, explants were fixed in 4% PFA.
Retinal whole-mount staining was performed and imaged as described
above. Images were quantified by counting number of filopodia per 100 µm
of leading edge per image. For further details, see supplementary Materials
and Methods.
Vascular leakage assay
Measurement of vascular leakage in ear skin was performed during steady
state and after systemic injection of 1 μg human VEGF-A165, as described
(Proulx et al., 2013). Adult WT, heterozygous and homozygous Sema3A-
cECKO littermates were imaged. Regions of interest (ROIs) over each ear and
the saphenous vein were used to define signal intensity values. Tissue leakage
rates (per min) were defined as the slope of the ear ROI intensity divided by
the saphenous vein ROI intensity plotted over time (Proulx et al., 2013).
Statistical analyses
Statistical analyses were performed using Prism v5.0 (GraphPad). Data are
shown as means±s.d. and were analyzed with a two-tailed, unpaired
Student’s t-test when two groups were compared. A one-way ANOVAwith
Dunnett’s post hoc test was used when more than two groups were
compared. The evenness of leading edge was analyzed with a 2×3
contingency table using Fisher’s exact test.
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